Part, Chapter, Paragraph
1 II, 5. 1. 1| low density lipoprotein cholesterol, high blood pressure, diabetes,
2 II, 5. 1. 1| elevated total and LDL cholesterol, low HDL cholesterol, hypertension,
3 II, 5. 1. 1| LDL cholesterol, low HDL cholesterol, hypertension, diabetes
4 II, 5. 1. 1| high blood pressure or high cholesterol;~· type 2 diabetes runs
5 II, 5. 2. 2| low density lipoprotein cholesterol, high blood pressure, diabetes,
6 II, 5. 2. 2| elevated total and LDL cholesterol, low HDL cholesterol, hypertension,
7 II, 5. 2. 2| LDL cholesterol, low HDL cholesterol, hypertension, diabetes
8 II, 5. 2. 3| risk factors, such as serum cholesterol and blood pressure, and
9 II, 5. 2. 4| pressure, obesity, blood cholesterol and tobacco use would more
10 II, 5. 2. 4| pressure, LDL and total cholesterol, physical inactivity and
11 II, 5. 2. 4| incidence (age, blood pressure, cholesterol, body mass index) and the
12 II, 5. 2. 4| 2.8 shows data on total cholesterol: prevalence of hypercholesterolemia
13 II, 5. 2. 4| Estimated mean values of total cholesterol in mmol/l and prevalence
14 II, 5. 2. 4| high-density lipoprotein (HDL) cholesterol and glycaemia (Panico et
15 II, 5. 2. 4| participating countries and also in cholesterol in many of them. According
16 II, 5. 2. 4| blood pressure (mmHg), total cholesterol (mmol/L) and BMI (Kg/m2 )
17 II, 5. 2. 5| systolic blood pressure, cholesterol and diabetes considered
18 II, 5. 2. 5| treatment targets for LDL cholesterol and blood pressure in individuals
19 II, 5. 2. 5| foods rich in preformed cholesterol, a moderate intake of salt
20 II, 5. 2. 5| were documented in smoking, cholesterol and blood pressure. By 1992,
21 II, 5. 2. 6| factors such as smoking habit, cholesterol, blood pressure, obesity
22 II, 5. 2. 6| progress and outcomes.~ ~Plasma cholesterol levels and CVD risk~Observational
23 II, 5. 2. 6| average level of total plasma cholesterol in different countries is
24 II, 5. 2. 6| association between plasma cholesterol levels and CHD risk was
25 II, 5. 2. 6| extends to values of plasma cholesterol well below those usually
26 II, 5. 2. 6| 80s, that total and LDL cholesterol reduction causes a reduction
27 II, 5. 2. 6| reduction of plasma LDL cholesterol levels by 1% will induce
28 II, 5. 2. 6| association of stroke with plasma cholesterol levels is weak, or absent,
29 II, 5. 2. 6| mechanistic point of view, cholesterol reduction has been shown
30 II, 5. 2. 6| useful to control plasma cholesterol levels and the availability
31 II, 5. 2. 6| of drugs able to inhibit cholesterol synthesis and absorption
32 II, 5. 2. 6| therapeutic target (plasma cholesterol levels ranging from 70 mg/
33 II, 5. 2. 6| Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT)
34 II, 5. 2. 6| Studies Collaboration: Blood cholesterol and vascular mortality by
35 II, 5. 2. 6| statins: benefit beyond cholesterol reduction? A meta-regression
36 II, 5. 2. 6| relationship between serum cholesterol and risk of premature death
37 II, 5. 2. 7| trials for the National Cholesterol Education Program Adult
38 II, 5. 2. 7| Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc
39 II, 5. 4. 1| increased blood levels of total cholesterol and triglycerides. High
40 II, 5. 4. 2| HbA1c testing~Annual LDL cholesterol testing~Annual screening
41 II, 5. 4. 2| last 12 months with total cholesterol>5 mmol/l~14~Percent of diabetic
42 II, 5. 4. 2| level.~Measurement of total cholesterol in the last 12 months is
43 II, 5. 4. 2| population that had their total cholesterol tested in the last 12 months.~
44 II, 5. 4. 2| the last 12 months.~Total cholesterol level>5 mmol/l is an important
45 II, 5. 4. 2| population with their total cholesterol tested in last 12 months
46 II, 5. 4. 2| 12 months showing a total cholesterol above 5 mmol/l.~Measurement
47 II, 5. 4. 2| mmol/l.~Measurement of LDL cholesterol in the last 12 months is
48 II, 5. 4. 2| the last 12 months.~LDL cholesterol level >2.6 mmol/l is an
49 II, 5. 4. 2| mmol/l.~Measurement of HDL cholesterol in the last 12 months is
50 II, 5. 4. 2| the last 12 months.~HDL cholesterol level <1.0 mmol/l for men
51 II, 5. 4. 2| the last 12 months and HDL cholesterol below 1.0 for men and 1.
52 II, 5. 4. 2| population with their total cholesterol tested in last 12 months
53 II, 5. 4. 2| 12 months showing a total cholesterol above 2.3 mmol/l.~Microalbuminuria
54 II, 5. 4. 3| age.~Measurement of total cholesterol in the last 12 months. EUCID
55 II, 5. 4. 3| median value of 87%.~Total cholesterol level>5 mmol/l. In EUCID
56 II, 5. 4. 3| percentage.~Measurement of LDL cholesterol in the last 12 months. The
57 II, 5. 4. 3| the treatment of elevated cholesterol is based on total and HDL
58 II, 5. 4. 3| is based on total and HDL cholesterol. The decrease in patients
59 II, 5. 4. 3| recommendations for testing.~LDL cholesterol level >2.6 mmol/l. Crude
60 II, 5. 4. 3| effect.~Measurement of HDL cholesterol in the last 12 months. The
61 II, 5. 4. 3| and people above 65.~HDL cholesterol level <1.0 mmol/l for men
62 II, 5. 4. 5| high blood pressure or high cholesterol;~- type 2 diabetes familiarity;~-
63 II, 5. 4. 6| blood pressure and high cholesterol, see Chapter 5.2.4. and
64 II, 5. 13 | blood pressure, high blood cholesterol level, high BMI, low fruit
65 II, 9. 2. 3| adiposity, raised HDL blood cholesterol, raised blood triglycerides,
66 II, 9. 3. 1| growing that lowering blood cholesterol levels and treating severe
67 III, 10. 1 | particles~food, e.g. high cholesterol~stress~ ~Respiratory diseases,
68 III, 10. 2. 1| cardiovascular disease, such as high cholesterol levels in blood and hypertension (
69 III, 10. 2. 1| blood pressure, high blood cholesterol level, high BMI, low fruit
70 III, 10. 2. 1| low-density lipoprotein cholesterol, a low level of high-density
71 III, 10. 2. 1| high-density lipoprotein cholesterol and a high gestational weight
72 III, 10. 2. 1| fibre” and “helps lower cholesterol”) on foodstuffs based on
73 III, 10. 2. 2| 10.2.2. Plasma cholesterol levels.~ ~Observational
74 III, 10. 2. 2| average level of total plasma cholesterol in different countries is
75 III, 10. 2. 2| association between plasma cholesterol levels and CHD risk was
76 III, 10. 2. 2| extends to values of plasma cholesterol well below those usually
77 III, 10. 2. 2| increase in plasma total cholesterol is associated with an increase
78 III, 10. 2. 2| reduction in plasma total cholesterol is followed by a 25% reduction
79 III, 10. 2. 2| in populations with total cholesterol less than 3-4 mmol/l (~
80 III, 10. 2. 2| reduction of plasma LDL cholesterol levels by 1% will induce,
81 III, 10. 2. 2| association of stroke with plasma cholesterol levels is weak, or absent,
82 III, 10. 2. 2| mechanistic point of view, cholesterol reduction has been shown
83 III, 10. 2. 2| useful to control plasma cholesterol levels as well as the availability
84 III, 10. 2. 2| of drugs able to inhibit cholesterol synthesis and absorption
85 III, 10. 2. 2| therapeutic target (plasma cholesterol levels ranging from 70 mg/
86 III, 10. 3. 2| particles~food, e.g. high cholesterol~stress~ ~Respiratory diseases,
87 IV, 11. 1. 5| patient blood pressure and cholesterol targets in the UK GP contract,
88 IV, 12. 2 | treatment targets for LDL cholesterol and blood pressure in individuals
89 IV, 12. 2 | foods rich in preformed cholesterol, a moderate intake of salt
90 IV, 12. 2 | were documented in smoking, cholesterol and blood pressure. By 1992,
91 IV, 12. 2 | blood pressure and high cholesterol. Because of the increase
92 IV, 12. 10 | Hypertension, Obesity, Cholesterol, Cancer, AIDS, Diabetes
93 IV, 13. 2. 3| hypertension, 7.4% and 7.4% to high cholesterol and obesity. Worldwide,
94 IV, 13. 2. 4| overweight, high blood levels of cholesterol and physically inactivity.
95 Key, Ap5. 0. 0| children~chlamydia~chloride~cholesterol~chromium~cigarette~cigarettes~
